Selektivní Imunosupresiva – Vedolizumab VII.
Economic Operator with Whom the Contract Has Been Concluded
| Show detail | ||||||||
|---|---|---|---|---|---|---|---|---|
| 35397393 | 22. 04. 2026 | Takeda Pharmaceuticals Czech Republic s.r.o. | 112 617 120,00 | 100 551 000,00 | 112 617 120,00 | 100 551 000,00 | CZK |
Published Documents
| Show detail | |||||
|---|---|---|---|---|---|
| 131_Pisemna_zprava_1_.pdf_podepsano.pdf | Písemná zpráva zadavatele | 28. 04. 2026 09:46 | Dokument není zavirovaný |
List of Participants
| Show detail | |||||||
|---|---|---|---|---|---|---|---|
| Takeda Pharmaceuticals Czech Republic s.r.o. | Praha | 100 550 882,00 | CZK | Yes | Yes |